Ticagrelor-Induced Prolongation of the QTc Interval

BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...

Full description

Saved in:
Bibliographic Details
Published in:Case Rep Cardiol
Main Authors: Ray, Avik, Najmi, Ahmad, Khandelwal, Gaurav, Sadasivam, Balakrishnan
Format: Artigo
Language:Inglês
Published: Hindawi 2019
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/
https://ncbi.nlm.nih.gov/pubmed/31827937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items